Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Translational Molecular Hematology

Whereas clinical hematology is the branch of medicine concerned with the study, diagnosis, treatment, and prevention of blood disorders, molecular hematology can be defined as the study of hematopoiesis from a molecular and genetic perspective. For several decades, the hematopoietic system has been the foremost biological model when investigating human malignant disease. Seminal findings in both the laboratory and clinical setting have resulted in a staggering increase of survival in pediatric leukemia, as well as a plethora of new therapeutic tools, making hematology a model of modern translational research.

The main goal of our laboratory is to use the current understanding of hematopoiesis and put this in a clinical context, to be able to employ this knowledge in identifying new biomarkers and potential therapeutic targets for primarily pediatric blood disorders. In addition, another goal is to take novel clinical discoveries, e.g. mutations or epigenetic findings linked to specific hematopoietic pathophenotypes, and use them as a foundation for basic research projects regarding hematopoietic stem and progenitor cell regulation and function.

Josef Davidsson
Digital Droplet PCR demonstrating a novel bone marrow dysplasia associated familial mutation in, from top, one carrier (variant allele frequency, VAF 50%), one mosaic carrier (VAF 20%) and one healthy non-carrier family member, respectively. Image: Josef
Page Manager:

Molecular Hematology
Department of Laboratory Medicine, Faculty of Medicine
Lund University
Box 117
SE-221 00 LUND

E-mail & phone: info [at] med [dot] lu [dot] se  +46 (0)46 222 0000